Technical Analysis for CANF - Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Grade Last Price % Change Price Change
D 2.22 -1.77% -0.04
CANF closed down 1.77 percent on Thursday, March 28, 2024, on 36 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
Bearish Engulfing Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Gapped Up Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
MACD Bullish Signal Line Cross Bullish -1.77%
180 Bullish Setup Bullish Swing Setup -1.77%
Bollinger Band Squeeze Range Contraction -1.77%
Gapped Up Strength -1.77%
MACD Bearish Signal Line Cross Bearish 1.83%

   Recent Intraday Alerts

Alert Time
Down 1% about 14 hours ago
Upper Bollinger Band Resistance about 14 hours ago
Bullish 180 Entry about 15 hours ago
Rose Above Previous Day's High about 15 hours ago
Rose Above Upper Bollinger Band about 15 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Can-Fite BioPharma, Ltd., a biotechnology company, develops drugs for the treatment of cancer and autoimmune inflammatory diseases. The company principally develops CF101 that is in Phase III study for the treatment of psoriasis; and has completed Phase II study for the treatment of rheumatoid arthritis and glaucoma, as well as completed Phase III study for the treatment of dry eye and Phase I study for the treatment of uveitis. It also develops CF102, which is in Phase II study for the treatment of hepatocellular carcinoma; and CF602 that has completed pre-clinical trial for the treatment of inflammatory diseases. The company was founded in 2000 and is based in Petach Tikva, Israel.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Immunology Treatment Of Cancer Inflammatory Diseases Rheumatoid Arthritis Psoriasis Carcinoma Glaucoma Arthritis Hepatocellular Carcinoma Uveitis Immunosuppressants Biotie Therapies Treatment Of Inflammatory Disease Treatment Of Inflammatory Diseases Treatment Of Psoriasis

Is CANF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.33
52 Week Low 1.53
Average Volume 20,006
200-Day Moving Average 2.41
50-Day Moving Average 2.10
20-Day Moving Average 2.18
10-Day Moving Average 2.20
Average True Range 0.09
RSI (14) 54.95
ADX 20.65
+DI 15.52
-DI 12.69
Chandelier Exit (Long, 3 ATRs) 2.02
Chandelier Exit (Short, 3 ATRs) 2.31
Upper Bollinger Bands 2.27
Lower Bollinger Band 2.09
Percent B (%b) 0.71
BandWidth 8.35
MACD Line 0.03
MACD Signal Line 0.03
MACD Histogram 0.0011
Fundamentals Value
Market Cap 13.42 Million
Num Shares 6.05 Million
EPS -1.48
Price-to-Earnings (P/E) Ratio -1.50
Price-to-Sales 17.07
Price-to-Book 2.38
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.34
Resistance 3 (R3) 2.35 2.33 2.32
Resistance 2 (R2) 2.33 2.30 2.32 2.31
Resistance 1 (R1) 2.27 2.28 2.26 2.26 2.31
Pivot Point 2.25 2.25 2.24 2.24 2.25
Support 1 (S1) 2.19 2.22 2.18 2.18 2.13
Support 2 (S2) 2.17 2.20 2.16 2.13
Support 3 (S3) 2.11 2.17 2.12
Support 4 (S4) 2.10